| Current Price | $37.27 | Mkt Cap | $3.3B |
|---|---|---|---|
| Open | $36.25 | P/E Ratio | 0.00 |
| Prev. Close | $37.27 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $35.67 - $37.64 | Volume | 1,121,215 |
| 52-Wk Range | $32.44 - $77.38 | Avg. Daily Vol. | 1,162,508 |
| Current Price | $37.27 | Mkt Cap | $3.3B |
|---|---|---|---|
| Open | $36.25 | P/E Ratio | 0.00 |
| Prev. Close | $37.27 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $35.67 - $37.64 | Volume | 1,121,215 |
| 52-Wk Range | $32.44 - $77.38 | Avg. Daily Vol. | 1,162,508 |
The best Bull and Bear pitches based on recency and number of recommendations.
CRSPR in vivo success would position for many new therapies and industry leadership
There are no pitches that meet the Top Bear criteria. Explain
If this upsets you, start recommending pitches below!
Read the most recent pitches from players about NTLA.
Recs
TMFSecurity
(92.71)
Submitted: 11/16/2021 8:22:40 AM :
Start Price:
$132.82
NASDAQ:NTLA Score:
+59.42
10000000146
Recs
TMFRetireFoolish
(< 20)
Submitted: 7/8/2021 1:22:52 AM :
Start Price:
$151.10
NASDAQ:NTLA Score:
-70.63
CRSPR in vivo success would position for many new therapies and industry leadership
Recs
TMFbonefish
(37.58)
Submitted: 5/5/2021 5:06:08 PM :
Start Price:
$72.96
NASDAQ:NTLA Score:
-47.24
It's hard not to imagine gene-editing as the future of medicine. The company has about $600 million in cash and short-term investments on its balance sheet, and recently received funding from the Bill & Melinda Gates Foundation. That cash cushion is important. Even if the company eventually delivers a treatment or treatments that lead to commercial success, that won't happen for a least a few years. For investors, therefore, owning Intellia stock requires a leap of faith.
Find the members with the highest scoring picks in NTLA.
allforone (75.94) Score: +924.49
The Score Leader is the player with the highest score across all their picks in NTLA.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| birdup | < 20 | 3/16/2020 |
|
5Y | $9.87 | +276.70% | +69.45% | +207.25 | 0 Comment | |
| Playa14 | < 20 | 10/17/2019 |
|
5Y | $11.40 | +226.14% | +36.67% | +189.47 | 0 Comment | |
| TraderEnvy | < 20 | 10/4/2019 |
|
5Y | $11.94 | +211.39% | +40.19% | +171.20 | 0 Comment | |
|
Kevinkress | < 20 | 5/4/2020 |
|
5Y | $13.09 | +184.03% | +45.47% | +138.56 | 0 Comment |
| 3dw4rdN1gm4 | 45.61 | 2/5/2020 |
|
5Y | $14.20 | +161.83% | +23.31% | +138.52 | 0 Comment | |
| k3ythd4vid | 50.03 | 2/5/2020 |
|
5Y | $14.20 | +161.83% | +23.45% | +138.38 | 0 Comment | |
|
|
ldigout | 73.67 | 4/13/2020 |
|
5Y | $13.05 | +184.90% | +47.23% | +137.67 | 0 Comment |
| LukeCrumb | 68.03 |
|
|
5Y | $14.74 | +152.24% | +21.47% | +130.77 | 0 Comment | |
| ZabasJ | 20.22 | 4/21/2020 |
|
5Y | $13.33 | +178.91% | +48.78% | +130.13 | 0 Comment | |
| steveo23 | 37.05 | 4/21/2020 |
|
5Y | $13.45 | +176.43% | +47.54% | +128.89 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
